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to propose that vaccination be 
compulsory for girls entering 
sixth grade. Parents who objected 
would be able to opt out of the 
requirement under the same pro-
visions that apply to other vacci-
nations. The bill passed the state 
senate by an overwhelming mar-
gin a week later and awaits con-
sideration by the house. Other 
states are likely to follow Michi-
gan’s lead.
The development of Gardasil, 
Merck’s HPV vaccine, is of major 
public health importance. The vac-
cine protects against four strains 
of HPV, the most common sexu-
ally transmitted disease in the 
United States, including the two 
strains that cause most cases of 
cervical cancer. More than 6 mil-
lion people in this country become 
infected with HPV every year, and 
nearly 10,000 women are diag-
nosed with cervical cancer. Be-
cause the vaccine has the greatest 
benefit when it is given before a 
person becomes sexually active, 
the Advisory Committee on Im-
munization Practices of the Cen-
ters for Disease Control and Pre-
vention recommended that it be 
given routinely to girls at 11 or 12 
years of age; it is not yet approved 
for use in boys. The committee 
took no position on whether vac-
cination should be required by law; 
such policy decisions are made by 
individual states.
Moves to make the vaccine 
compulsory are sure to ignite a 
new round of polarizing debates. 
Controversy over the product be-
gan before it was licensed, when 
some religious conservatives ex-
pressed concern that the avail-
ability of a vaccine against a sex-
ually transmitted disease would 
undermine abstinence-based pre-
vention messages. Advocacy groups 
such as Focus on the Family ulti-
mately came to support availabil-
ity of the vaccine, but they remain 
opposed to mandating its use. 
In their view, such a requirement 
constitutes an attempt by the sec-
ular state to force a child to un-
dergo an intervention that may be 
irreconcilable with her family’s 
religious values and beliefs.
It is a mistake, however, to 
view the contrasting stances on 
HPV-vaccine mandates as solely, 
or even primarily, evidence of a 
conflict between science and re-
ligion. A more complicated dy-
namic will shape the ongoing dis-
cussion.
On one side, support for legal 
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requirements is strongly influ-
enced by the perception of HPV as 
a women’s health issue. The severe 
consequences that the disease may 
have for women lends urgency to 
the effort to maximize use of the 
vaccine through all policy means, 
including mandates. Women in 
Government, a Washington-based, 
bipartisan organization of female 
legislators, is leading a push to 
make HPV vaccination compulso-
ry in every state. The group has 
issued recommendations for en-
suring that the vaccine is acces-
sible and affordable, including a 
recommendation that states add 
it to their Medicaid programs and 
encourage private health plans to 
cover it. The group follows in the 
tradition of breast-cancer activ-
ists, who have mobilized through 
many political channels to com-
bat an illness that disproportion-
ately burdens women.
On the other side, opposition 
to mandates will come from a far 
wider range of constituencies than 
just religious conservatives wor-
ried about threats to teenagers’ 
sexual abstinence. Vaccine require-
ments — even generally well-
accepted laws covering “classic” 
childhood diseases such as polio, 
measles, and pertussis — have 
been resisted in recent years on 
a wide range of philosophical, po-
litical, scientific, and ideological 
grounds.
During the past two decades, 
in the face of a sharp increase in 
the number of recommended pe-
diatric vaccines, unproven theo-
ries alleging connections between 
vaccines and illnesses including 
autism, diabetes, and multiple 
sclerosis have been spreading. A 
social movement involving diverse 
participants has challenged the 
safety of vaccination and mount-
ed attacks in courtrooms and leg-
islatures on compulsory vaccina-
tion laws. Forty-eight states allow 
parents who object to vaccination 
on religious grounds to excuse 
their children from requirements, 
and 20 of those states also allow 
exemptions for parents who have 
secular philosophical concerns.1 
Approximately 1 to 3% of U.S. 
children are excused by their par-
ents from vaccine requirements, 
though the rate varies from state 
to state; schools in a few commu-
nities have exemption rates as 
high as 15 to 20%. Activists have 
sought to liberalize the circum-
stances under which parents may 
opt out of vaccine requirements, 
a trend that reflects the wide 
variation in people’s reasons for 
rejecting vaccines: devotion to 
“natural” or alternative healing, 
libertarian opposition to state 
power, mistrust of pharmaceuti-
cal companies, belief that vaccines 
are not as safe as experts claim, 
and conviction that children re-
ceive more shots than are good 
for them.2
Laws making vaccination com-
pulsory raise unique ethical and 
policy issues. High levels of herd 
immunity protect all members of 
the community, including those 
who cannot receive vaccines be-
cause of medical contraindica-
tions. This protection provides a 
justification for compulsion. The 
availability of religious or philo-
sophical exemptions mitigates 
concern about governmental in-
trusion on individual decision 
making. Opinions vary, however, 
about the permissible scope of ex-
emptions. Data show that schools 
with exemption rates as low as 
2 to 4% are at increased risk for 
disease outbreaks and that chil-
dren who have been exempted 
from vaccine requirements have 
a much greater risk of acquiring 
infectious diseases than their vac-
cinated peers.1 Minors have a right 
to be protected against vaccine-
preventable illness, and society has 
an interest in safeguarding the 
welfare of children who may be 
harmed by the choices of their 
parents or guardians.
Bioethicists, who generally hold 
the values of patient autonomy 
and informed consent to be pre-
eminent, tend to be skeptical about 
compulsory vaccination laws. Not 
surprisingly, some have expressed 
wariness about or opposition to 
mandating HPV vaccination.3,4 Be-
cause HPV is not casually trans-
missible, they argue, there is a 
less compelling rationale for re-
quiring protection against it than 
against measles or pertussis, for 
instance; in the absence of poten-
tial harm to a third party, such 
laws may be considered unaccept-
ably paternalistic. Similar concerns 
have been raised about school-
based requirements for vaccina-
tion against hepatitis B: because 
the virus spreads primarily among 
sexually active people and injec-
tion-drug users, some parents ar-
gued that the vaccine should be 
given only to those groups rather 
than to all children. Such target-
ing of the vaccine, however, proved 
to be less effective than universal 
vaccination in reducing the inci-
dence of the disease.
A large body of evidence dem-
onstrates that school-based laws 
are an effective and efficient way 
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of boosting vaccine-coverage rates. 
Requiring HPV vaccination by law 
will almost certainly achieve more 
widespread protection against the 
disease than will policies that 
rely exclusively on persuasion and 
education. In the view of advo-
cates, this effectiveness provides 
a clear justification. “The only 
way to ensure that as many girls 
as possible receive the HPV vac-
cine is to require it before they 
enter middle school,” said Bev-
erly Hammerstrom, the Michi-
gan state senator who introduced 
the legislation. Whether such a 
mandate might extend to boys, 
should the product be approved 
for such use, remains uncertain.
A critical question is whether 
achieving a higher level of cov-
erage justifies the infringement 
on parental autonomy that com-
pulsory vaccination inevitably en-
tails. Different ethical frameworks 
that accord varying weights to 
communitarian and individualis-
tic values will lead to contrasting 
answers to this question.
Ethical and epidemiologic 
analyses are essential to decisions 
about mandating the HPV vaccine; 
so are political calculations. Any 
new vaccine that a state adds to 
its list of requirements must be 
judged in the context of both the 
increasingly lengthy and complex 
regimen of vaccines that children 
now receive and the possibility 
that additional mandates may in-
flame grassroots opposition, be it 
religious, philosophical, or ideo-
logical.5 Although issues of reli-
gion and adolescent sexuality have 
dominated the discussion, the 
move to require HPV vaccination 
raises broad questions about the 
acceptability of mandatory pub-
lic health measures, the scope of 
parental autonomy, and the role 
of political advocacy in determin-
ing how preventive health mea-
sures are implemented.
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Exploring the Uses of RNAi — Gene Knockdown 
and the Nobel Prize
René Bernards, Ph.D.
The Nobel Prize in Physiology or Medicine was awarded this 
year to Andrew Fire (Stanford Uni-
versity School of Medicine) and 
Craig Mello (University of Massa-
chusetts Medical School) for their 
discovery of a new form of gene 
silencing. Nearly 9 years ago, Fire 
and Mello and their colleagues 
reported that exposing cells of the 
nematode Caenorhabditis elegans to 
double-stranded RNA resulted in 
specific and efficient gene silenc-
ing.1 They also observed that 
double-stranded RNA is far more 
potent than sense or antisense 
RNA in silencing the gene that 
shares its sequence, and they 
dubbed the silencing process “RNA 
interference” (RNAi). Because 
RNAi rarely leads to the complete 
abrogation of gene expression, 
its effect is often described as a 
“knockdown” of gene expression. 
At first glance, RNAi seems sim-
ilar to the antisense approach to 
gene silencing, but it is far more 
effective and has a different mech-
anism.
In plants and nematodes, the 
introduction of long double-
stranded RNA into a cell leads 
to its cleavage into shorter frag-
ments. These fragments are pow-
erful silencers of gene expression 
and are therefore called “small 
interfering RNA” (siRNA). They 
are recruited into a protein com-
plex that positions the antisense 
strand so that it acts as a snare 
for the RNA transcript to which 
it is complementary. Once bound 
to this snare, the RNA transcript 
is cleaved by the complex and is 
degraded (see diagram). In lower 
organisms, RNAi is thought to 
function as a primitive immune 
system, protecting against viruses 
(which often generate double-
stranded RNA as replication inter-
mediates) and transposable ele-
ments (also known as “jumping 
genes”).
In most mammalian cells, long 
double-stranded RNA provokes an 
interferon response as part of an 
antiviral defense. This interferon 
response induces a global shut-
down of protein synthesis, thus 
precluding the use of long double-
stranded RNA for specific gene 
silencing. This obstacle can be 
overcome by using short double-
stranded RNA (less than 30 base 
pairs in length), which evades the 
radar of the mammalian interfer-
